Researchers at Columbia University have successfully edited the DNA of human embryos using a new technique called base editing, which allows for precise genetic alterations. This advancement raises ethical concerns about the potential for 'engineered babies' and the implications of selecting traits before birth.

• 01The team targeted genes linked to heart disease and hemoglobin production, successfully editing both in some embryos.
• 02Base editing avoids the extensive damage associated with earlier CRISPR methods but can still result in 'mosaic' embryos with mixed genetic changes.
• 03Experts urge caution, highlighting the need for thorough safety checks and the potential for unforeseen effects post-birth.
• 04The research could benefit IVF by allowing the selection of embryos without disease-causing mutations.
• 05Concerns persist about the ethical implications of using such technology for selecting traits beyond disease prevention.

The advancement in DNA editing could transform IVF practices, allowing for healthier embryo selection and potentially reducing the prevalence of genetic disorders.